Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 618,408 |
|
|||||
| News | - |
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Renalytix PLC | RNLX | NASDAQ | Depository Receipt |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0138 | 2.21% | 0.638 | 16:23:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.669 | 0.59 | 0.669 | 0.6288 | 0.6242 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume |
|---|---|---|---|---|
| 1,027 | 618,408 | 0.6157953 | 380,813 | - |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:01:13 | 5 | 0.6388 | USD |
Renalytix PLC Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 22.98M | 93.78M | - | 3.4M | -46.22M | -0.49 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Renalytix
| Date | Time | Source | Heading |
|---|---|---|---|
| 4/08/2024 | 06:00 | GlobeNewswire Inc. | Renalytix Announces Financing with Expected Size of up to $4.. |
| 3/14/2024 | 06:00 | GlobeNewswire Inc. | KidneyIntelX™ included in Final KDIGO 2024 Clinical.. |
| 2/15/2024 | 06:00 | GlobeNewswire Inc. | Renalytix Reports Financial Results for Second Quarter of.. |
| 2/15/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/14/2024 | 15:31 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2/09/2024 | 08:00 | GlobeNewswire Inc. | Renalytix to Participate in the BTIG MedTech, Digital.. |
| 1/17/2024 | 06:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/10/2024 | 06:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/10/2024 | 06:00 | GlobeNewswire Inc. | New published data demonstrates KidneyIntelX™ has broad.. |
| 12/29/2023 | 15:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/17/2023 | 15:01 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
| 11/14/2023 | 06:00 | GlobeNewswire Inc. | Renalytix Reports Financial Results for First Quarter of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
RNLX Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The company's lead product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. |
